Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,574.80
(
-0.62%
)
Dow Jones
46,021.43
(
0.00%
)
Brent Oil
104.67
(
0.23%
)
Bitcoin
70,561.99
(
0.95%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: flatlander_60048 post# 97327

Wednesday, 06/16/2010 5:33:59 PM

Wednesday, June 16, 2010 5:33:59 PM

Post# of 257262

Does PFE opening a rare-disease research center indicate that they are adopting a strategy similar to NVS.

Hi, FL. I would submit that everything PFE has been doing for the past few years has been an attempt to steer the company closer to NVS’ business model. Dan Vasella predicted this would eventually happen as long ago as 2003, when PFE acquired Pharmacia.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now